Screener
Sarepta Therapeutics, Inc. SRPT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s total equity?
- Sarepta Therapeutics, Inc. (SRPT) reported total equity of $1.53B in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s total equity changed year-over-year?
- Sarepta Therapeutics, Inc.'s total equity increased by 8.8% year-over-year, from $1.4B to $1.53B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total equity has grown at a 8.4% compound annual growth rate (CAGR), from $761.76M to $1.14B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Sarepta Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude